Good morning and welcome to PDS Biotech's 4th quarter in full year 2024 earnings conference call. Thank you, operator. Good morning, everyone, and welcome to PDS Biotech's 2024 results and clinical ...

Phase 1 dose-escalation study continues with data readout expected mid-2025; Dose expansion data readout anticipated ...

Q4 2024 Earnings Conference Call March 27, 2025 4:30 PM ETCompany ParticipantsBruce Mackle - LifeSci Advisors, ...

Trastuzumab botidotin has met the primary endpoints of its pivotal Phase 2 trial for 3L+ advanced HER2+ BC based on results from the primary analysis, which the Company used to submit an NDA to the ...

Why Alloy Development, Neutral, and Onx are among Fast Company’s Most Innovative Companies in urban development and real ...

It is not normal to have a business owner like Elon Musk, whose financial interests are closely entwined with government ...

“We achieved significant progress across ... potentially best-in-class profile. In the updated dataset, safety was consistent with prior results, and APG777 demonstrated a favorable pharmacodynamic ...

Assassin’s Creed Shadows takes the series through the late Sengoku period of Japan, set roughly between the 1570s and 1600 ...

Q4 2024 Earnings Call Transcript March 13, 2025 Allogene Therapeutics, Inc. beats earnings expectations. Reported EPS is ...

He swiped around for a second and said, “Oh. It’s just like my phone.” It is just like his phone — a six-year-old iPhone XR — only updated with a few essential improvements (a faster processor, nicer ...

Operator Greetings and welcome to the 3D Systems fourth quarter and fiscal year 2024 earnings conference call and webcast. At ...

Discover actionable strategies tailored to your specific procrastination patterns so you can reclaim your productivity.